211 results on '"de Leng, Wendy W J"'
Search Results
2. Towards diagnostic criteria for malignant deep penetrating melanocytic tumors using single nucleotide polymorphism array and next-generation sequencing
3. Comparative Performance Analysis of Idylla and Archer in the Detection of Gene Fusions in Spitzoid Melanocytic Tumors
4. Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP)
5. Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol
6. Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma:Results From the Drug Rediscovery Protocol
7. Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol
8. Next generation sequencing of high-grade adult-type diffuse glioma in the Netherlands: interlaboratory variation in the primary diagnostic and recurrent setting
9. RT-PCR assay to detect FGFR3::TACC3 fusions in formalin-fixed, paraffin-embedded glioblastoma samples.
10. mRNA Expression Level of ALK in Neuroblastoma Is Associated with Histological Subtype, ALK Mutations and ALK Immunohistochemical Protein Expression.
11. Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
12. RT-PCR assay to detect FGFR3::TACC3 fusions in formalin-fixed, paraffin-embedded glioblastoma samples
13. Clear cell chondrosarcoma in Von Hippel-Lindau disease
14. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type
15. Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: relation to grade, histopathology and overall survival in the GLASS-NL cohort
16. Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics
17. RT-PCR assay to detect FGFR3::TACC3fusions in formalin-fixed, paraffin-embedded glioblastoma samples
18. The decisive role of molecular pathology in presumed somatic metastases of type II testicular germ cell tumors: report of 2 cases
19. Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue
20. Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors
21. Formalin-Fixed, Paraffin-Embedded-Targeted Locus Capture: A Next-Generation Sequencing Technology for Accurate DNA-Based Gene Fusion Detection in Bone and Soft Tissue Tumors
22. Genetic Aspects and Molecular Testing in Prostate Cancer:A Report from a Dutch Multidisciplinary Consensus Meeting
23. Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort
24. Formalin-Fixed, Paraffin-Embedded-Targeted Locus Capture: A Next-Generation Sequencing Technology for Accurate DNA-Based Gene Fusion Detection in Bone and Soft Tissue Tumors
25. Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials
26. Diagnostic Utility of Menin Immunohistochemistry in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome
27. Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors
28. Genetic Aspects and Molecular Testing in Prostate Cancer: A Report from a Dutch Multidisciplinary Consensus Meeting
29. Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
30. Targeted locus amplification to develop robust patient-specific assays for liquid biopsies in pediatric solid tumors
31. One-fits-all pretreatment protocol facilitating Fluorescence In Situ Hybridization on formalin-fixed paraffin-embedded, fresh frozen and cytological slides
32. Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D‐CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials.
33. Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
34. Additional file 2 of Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
35. Stem cell dynamics and pretumor progression in the intestinal tract
36. Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma
37. Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma
38. Patients with bi-allelic BRCA1/2 inactivation respond to olaparib treatment across histologic tumor types
39. Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma
40. Genome methylation accurately predicts neuroendocrine tumor origin - an online tool
41. Multicenter comparison of Molecular Tumor Boards in the Netherlands: definition, composition, methods and targeted therapy recommendations
42. LKB1 as the ghostwriter of crypt history
43. The COX-2 promoter polymorphism –765 G>C is associated with early-onset, conventional and stump gastric cancers
44. Clinicopathologic and Molecular Features of Intracranial Desmoplastic Small Round Cell Tumors
45. Clinicopathologic and Molecular Features of Intracranial Desmoplastic Small Round Cell Tumors
46. The decisive role of molecular pathology in presumed somatic metastases of type II testicular germ cell tumors: Report of 2 cases
47. Role of diffusion weighted imaging for differentiating cerebral pilocytic astrocytoma and ganglioglioma BRAF V600E-mutant from wild type
48. Prognostic and Predictive Value of Integrated Qualitative and Quantitative Magnetic Resonance Imaging Analysis in Glioblastoma
49. Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers
50. Aberrant intestinal stem cell lineage dynamics in Peutz–Jeghers syndrome and familial adenomatous polyposis consistent with protracted clonal evolution in the crypt
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.